Polyethylene Glycol Nanoparticles as Promising Tools for Anticancer Therapeutics

This publication has 111 references indexed in Scilit:

• Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
  Cancer Chemotherapy and Pharmacology, 2013
• The Effect of Nanoparticle Polyethylene Glycol Surface Density on Ligand-Directed Tumor Targeting Studiedin Vivoby Dual Modality Imaging
  ACS Nano, 2012
• Uricases as Therapeutic Agents to Treat Refractory Gout: Current States and Future Directions
  Drug Development Research, 2012
• Synthesis and Properties of Star-Comb Polymers and Their Doxorubicin Conjugates
  Bioconjugate Chemistry, 2011
• Pegylated arginase I: a potential therapeutic approach in T-ALL
  Blood, 2010
• Delivery of Therapeutic Proteins
  Journal of Pharmaceutical Sciences, 2010
• Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
  Cancer Cell International, 2009
• Polymeric micelles from poly(ethylene glycol)–poly(amino acid) block copolymer for drug and gene delivery
  Journal of The Royal Society Interface, 2009
• Randomized Dose-Escalation Study Evaluating Peginterferon Alfa-2a in Patients With Metastatic Malignant Melanoma
  Journal of Clinical Oncology, 2006
• Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate
  Biomaterials, 2005